# Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/vandetanib-in-patients-with-previously-treated-ret-rearranged-advanced-non-small/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kiyotaka Yoh,Takashi Seto,Miyako Satouchi,Makoto Nishio,Noboru Yamamoto,Haruyasu Murakami,Naoyuki Nogami,Shingo Matsumoto,Takashi Kohno,Koji Tsuta,Katsuya Tsuchihara,Genichiro Ishii,Shogo Nomura,Akihiro Sato,Atsushi Ohtsu,Yuichiro Ohe,Kōichi Goto |
| Citations | 297 |
| DOI | 10.1016/s2213-2600(16)30322-8 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2547299751 |
| PMID | 27825616 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Kiyotaka Yoh](https://scholariq.org/researchers/kiyotaka-yoh/)
- [Genichiro Ishii](https://scholariq.org/researchers/genichiro-ishii/)
- [Shingo Matsumoto](https://scholariq.org/researchers/shingo-matsumoto/)
- [Kōichi Goto](https://scholariq.org/researchers/koichi-goto/)

## Paper journal

- [The Lancet Respiratory Medicine](https://scholariq.org/journals/the-lancet-respiratory-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.